Grants for Public Housing Authorities

The Parasol Tahoe Community Foundation's 2024 Community Impact Grant Cycle invites proposals to support organizations making a significant difference in the Tahoe Basin. The foundation's mission, though not explicitly detailed in this description, is clearly aligned with fostering community well-being and addressing critical needs within the Nevada and California areas of the Tahoe Basin. By offering grants ranging from $10,000 to $100,000, with a specific request amount up to $20,000, the foundation aims to empower eligible non-profits to enhance their services and achieve measurable community impact. The primary target beneficiaries are the residents and communities of the Tahoe Basin. Organizations seeking funding must directly provide more than 50% of their services in this region, ensuring that the grants directly benefit local populations. The impact goals are broad, focusing on various community needs that align with the non-profit's mission, as long as they are not among the excluded activities. The foundation seeks to support initiatives that contribute to a stronger, more vibrant Tahoe community, although specific impact metrics are not detailed in this overview. The foundation prioritizes supporting tax-exempt 501(c)(3) public charities or schools that have held their tax-exempt status for at least two years and are incorporated in good standing in Nevada or California. A key focus is on direct service provision within the Tahoe Basin. The grants are not awarded for direct religious activity, political lobbying, special event sponsorships, pass-through funding, or reimbursement of prior expenses. This careful delineation of exclusions highlights the foundation's strategic intent to fund direct, impactful, and non-duplicative community services. While specific strategic priorities and a detailed theory of change are not outlined, the grant cycle implicitly emphasizes strengthening local non-profits and their capacity to serve. The expected outcomes are improved community conditions and enhanced services for Tahoe Basin residents, facilitated by the financial support provided. The measurable results are tied to the successful implementation of projects by the funded organizations, though the specific reporting requirements for these results are not included in this description.

The "Type 1 Diabetes TrialNet Clinical Network Hub" grant aims to support the coordination unit for clinical trials focused on preventing and intervening early in type 1 diabetes, by improving communication, outreach, and developing new strategies for better screening, recruitment, and retention of participants.

With this solicitation, BJA seeks to support efforts by state, local, and federally recognized American Indian tribal governments to establish and enhance community courts in their jurisdictions. This program furthers the DOJs mission by providing resources to communities to enhance public safety and build trust between law enforcement and the community.

This grant provides funding for researchers to evaluate and develop effective strategies to prevent driving under the influence of multiple substances, particularly focusing on high-risk populations.

The U.S. Department of Justice (DOJ), Office of Justice Programs (OJP), Office for Victims of Crime (OVC) is seeking applications for funding. OJP is committed to advancing work that promotes civil rights and equity, increases access to justice, supports crime victims and individuals impacted by the justice system, strengthens community safety, protects the public from crime and evolving threats, and builds trust between law enforcement and the community. With this solicitation, OVC seeks to enable an organization to provide financial and technical assistance to approximately 300 communities (100 each year) nationwide to conduct public education and awareness activities on crime victims rights and services in their jurisdictions during the 20252027 National Crime Victims Rights Weeks (NCVRW). This program furthers the DOJs mission to uphold the rule of law, to keep our country safe, and to protect civil rights.

The purpose of the Housing-related Hazards Capital Fund (HRHCF) Lead-based Paint Capital Fund Program (LBPCF) Notice of Funds Opportunity (NOFO) is to evaluate and reduce residential health hazards in public housing, including lead-based paint, carbon monoxide, mold, radon, fire safety, and asbestos. In accordance with Section 9 of the United States Housing Act of 1937 (42 U.S.C. 1437g) (1937 Act), and the Consolidated Appropriations Act, 2024, $65 million shall be made available for competitive grants to public housing agencies to evaluate and reduce housing-related hazards including lead-based paint in public housing, whereas no less than $25 million of the $65 million of the available funds shall be awarded for evaluating and reducing lead-based paint hazards specifically by carrying out the activities of lead-based risk assessments, inspections, abatement, interim controls, and clearance examinations. In the event there are not enough eligible applications to award $25 million in competitive grants to evaluate and reduce lead-based paint hazards, any remaining amounts may be awarded to qualified applicants for evaluating and reducing housing-related hazards. These amounts are combined with an additional $19.5 million in carryover funding from the Consolidated Appropriations Act, 2023 for lead-based paint and approximately $3.3 million in recaptured funds from the Consolidated Appropriations Act, 2021 for lead-based paint. Although two grant programs are combined under one funding opportunity title, applicants will request funding from each grant program separately per the program requirements and application submission guidelines. Applicants are entitled to apply for one grant program or both. Applications will be competitively scored based on the unique rating factors for each individual program and funding may be awarded, fully or partially, under one program, both, or neither based on the rating, ranking, and funding available under each program. If the applicant is applying for funding under both grant programs, the rating and rankings will be determined separately.

This funding opportunity supports innovative research projects aimed at understanding and improving the diagnosis, treatment, and services for individuals with Autism Spectrum Disorders, welcoming applications from a diverse range of organizations, including universities and nonprofits.

This funding opportunity provides financial support for research aimed at developing and evaluating innovative strategies to prevent firearm-related violence and injuries, targeting eligible applicants such as state and local governments, educational institutions, nonprofits, and tribal entities.

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit research designed to capacitate, transform, and scale the delivery of HIV testing, prevention, and care services through pharmacists and pharmacies in US and/or global settings. This includes theadvancement of training curricula to enable pharmacy students, pharmacists, pharmacies, and pharmacy systems to deliver the spectrum of needed HIV services with ease, equity, and effectiveness. This NOFO uses the R21 grant mechanism, while RFA-MH-25-185 uses the R01 mechanism. Projects that lack preliminary data or that propose to pilot a novel intervention may be most appropriate for the R21 mechanism. Applications with preliminary data and those proposing large-scale clinical trials or longitudinal analyses should consider using the R01 mechanism.

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit research designed to capacitate, transform, and scale the delivery of HIV testing, prevention, and care services through pharmacists and pharmacies in US and/or global settings. This includes theadvancement of training curricula to enable pharmacy students, pharmacists, pharmacies, and pharmacy systems to deliver the spectrum of needed HIV services with ease, equity, and effectiveness. This NOFO uses the R01 grant mechanism, while RFA-MH-25-186 uses the R21 mechanism. Projects that lack preliminary data or that propose to pilot a novel intervention may be most appropriate for the R21 mechanism. Applications with preliminary data and those proposing large-scale clinical trials or longitudinal analyses should consider using the R01 mechanism.

The "Coordinating Center for Type 1 Diabetes TrialNet" grant aims to fund the TrialNet Coordinating Center, which conducts research, trials, and studies to prevent the progression of type 1 diabetes and preserve insulin production, while also managing data, samples, and network operations, and promoting diverse perspectives in its work.

This grant provides long-term funding to experienced researchers in heart, lung, blood, and sleep studies, allowing them the flexibility to pursue innovative and high-risk research programs.

This funding opportunity provides support for mid-career clinician-scientists to conduct patient-oriented research while mentoring early-stage clinical researchers.

The purpose of this Notice of Funding Opportunity (NOFO) is to address the needs of the maternal and pediatric HIV scientific community for research data translation and sharing. This initiative will support secondary data analyses using archived HIV/AIDS data and specimens to generate new research questions and findings relevant to the scientific mission and priorities of the NICHD, Maternal and Pediatric Infectious Disease Branch (MPIDB) and Office of AIDS Research (OAR). The goal of this initiative is to encourage applicants to leverage existing datasets and employ new and advanced analysis techniques to answer scientific questions about the epidemiology, pathogenesis, treatment, clinical manifestations and complications of HIV/AIDS in maternal, pediatric and adolescent populations.

This funding opportunity supports new entrepreneurs in small businesses by providing resources for their career development and research efforts, helping them grow their skills in technology and healthcare innovation.

This grant provides funding to mid-career clinicians to focus on patient-oriented research and mentor junior researchers, allowing them to dedicate a portion of their time to advancing clinical studies and developing new investigators in the field.

This grant provides long-term funding to experienced researchers in heart, lung, blood, and sleep studies, allowing them the flexibility to pursue innovative and ambitious research projects without the constraints of traditional grant applications.

This funding opportunity provides salary support and research resources for early-stage independent scientists conducting basic experimental studies with human participants, helping them advance their careers and contribute to national health priorities.

The "Engineering Durable HIV Vaccine Responses (ENDURE)" grant aims to fund research that explores the factors influencing the longevity of vaccine responses, with a focus on HIV, in order to improve vaccine design and development, and to devise better methods for measuring long-term immune responses.

This grant provides financial support to mid-career clinician-scientists to conduct patient-oriented research and mentor junior investigators while allowing them to reduce their clinical responsibilities.